Stock listing

NASDAQ:ETNB 89bio Inc Stock

Follow 89bio Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ETNB

$14.84 USD

Close on Oct 29, 2025 · No longer trades

Nov 11, 2019 to last close -28.7% · weekly closes, Nov 11, 2019 – Oct 29, 2025
Lowest – highest close
$2.09 – $41.77 USDSince Nov 11, 2019 · lowest May 9, 2022 · highest Mar 2, 2020

Delisted NASDAQ:ETNB no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ETNB
Asset type
Stock
Exchange
NASDAQ
Currency
USD

89bio Inc on 6ix

Decks
10 decks · latest Apr 9, 2025

Decks

DeckKindSlidesDate
Investor Presentation (April 2025)Investor deck74 slidesApr 9, 2025
Investor Presentation (December 2023)Investor deck69 slidesDec 6, 2023
Technical Presentation (March 2023)Technical24 slidesMar 22, 2023
Investor Presentation (February 2023)Investor deck47 slidesFeb 15, 2023
Technical Presentation (June 2022)Technical44 slidesJun 28, 2022
Technical Presentation (January 2022)Technical21 slidesJan 24, 2022
Investor Presentation (June 2021)Investor deck41 slidesJun 10, 2021
Investor Presentation (October 2020)Investor deck42 slidesOct 5, 2020
Technical Presentation (September 2020)Technical22 slidesSep 14, 2020
Investor Presentation (April 2020)Investor deck40 slidesApr 13, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rajeev M Shah
Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past)
Director · Since at least Nov 8, 2019
Martin Babler
Other companies: MapLight Therapeutics, Inc. (Member of the Audit Committee · Since at least Jun 23, 2026); Alumis Inc. (President, Chief Executive Officer and Chairman of the Board · Since at least Jun 27, 2024); Prelude Therapeutics Incorporated (Director · Since at least Jun 17, 2022); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past)
Director · Since at least Apr 13, 2024
Michael Hayden
Other companies: AbCellera Biologics Inc. (Lead Director · Since at least Dec 11, 2020); Ionis Pharmaceuticals, Inc. (Board Member · Since at least Sep 20, 2018); Aurinia Pharmaceuticals Inc (Director · Jan 1, 2021 – Jan 29, 2021 · Past); Xenon Pharmaceuticals Inc. (Director · May 25, 2016 – Jun 3, 2021 · Past)
Director · Since at least Nov 8, 2019
Tomer Kariv
Other companies: Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); LogicBio Therapeutics Inc (Director · Oct 18, 2018 – Dec 19, 2019 · Past); VBI Vaccines Inc. (Director · Jan 23, 2018 – Jan 31, 2019 · Past); Arno Therapeutics Inc (Director · Jan 12, 2016 – Sep 8, 2016 · Past)
Director · Nov 8, 2019 – Nov 11, 2019 · Past
Edward Morrow Atkinson III
Other companies: Vertex Pharmaceuticals Incorporated (EVP, Chief Technical Ops. Off. · Since at least Aug 29, 2023)
Director · Since at least Feb 17, 2022
Anat NaschitzDirector · Nov 8, 2019 – Apr 15, 2021 · Past
Ryan MartinsChief Financial Officer · Since at least Feb 5, 2022

Open People

Log in to ask 6ix AI your own questions about 89bio Inc.